-
Innovation Ranking
NewInnovation Ranking – Merrimack Pharmaceuticals Inc
Merrimack Pharmaceuticals Inc (Merrimack) is a clinical-stage biopharmaceutical company that develops and commercializes novel targeted solutions for the treatment of various types of cancers through its understanding of biological markers and cancer pathways. It's first commercial product was Onivyde (irinotecan liposome injection) a liposomal formulation for treating advanced pancreatic cancer patients. Merrimack is entitled to receive milestone payments related to sale of Onivyde and MM-436 to Ipsen SA. Merrimack is headquartered in Cambridge, Massachusetts, the US.
-
Track & Monitor
Chemotherapy in Pharmaceuticals: Platinum-based cancer drug compositions
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Platinum-based cancer drug compositions segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Company Profile
Merrimack Pharmaceuticals Inc – Company Profile
Merrimack Pharmaceuticals Inc (Merrimack) is a clinical-stage biopharmaceutical company that develops and commercializes novel targeted solutions for the treatment of various types of cancers through its understanding of biological markers and cancer pathways. Its first commercial product, Onivyde (irinotecan liposome injection), is a liposomal formulation for the treatment of advanced pancreatic cancer patients. Merrimack is headquartered in Cambridge, Massachusetts, the US.
Add to Basket -
Track & Monitor
Immuno-oncology in Pharmaceuticals: Tumour antibody serum compositions
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Tumour antibody serum compositions segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...
-
Product Insights
Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient’s sample. GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Colorectal Cancer Diagnostic Tests Pipeline Assessment report provides key information and...
-
Product Insights
Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Lung Cancer Diagnostic Tests include assays of mostly antibodies released in response to a lung cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Lung Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Product Insights
Pancreatic Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Pancreatic Cancer Diagnostic Tests include assays of mostly antibodies released in response to a pancreatic cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Pancreatic Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Sector Analysis
United States Respiratory Devices Market Outlook to 2025
“What is covered in the report about the “United States Respiratory Devices Market”? GlobalData’s “United States Respiratory Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Respiratory Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Humidifiers, Nebulizers, Non-Invasive Ventilation Masks & Circuits, Oxygen Concentrators, Oxygen Conservers, Positive Airway Pressure Devices, Respiratory Device Accessories and Ventilators. The United States Respiratory Devices...